Open Access

Discussion - Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events.

Congress Presentation

About the speakers

Professor Stefan James

Uppsala University, Uppsala (Sweden)
45 presentations
2 followers

Professor Dominick Joseph Angiolillo

University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)
26 presentations
2 followers

Professor Stephen Nicholls

Monash University, Melbourne (Australia)
51 presentations
4 followers

Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)
29 presentations
1 follower

4 more presentations in this session

Welcome and Introduction - Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events.

Speaker: Professor S. James (Uppsala, SE)

Thumbnail

Seeing is believing, visualising long term risk: vulnerable plaque versus vulnerable patient.

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Call to action, pharmacotherapeutic approaches to reducing long term risk: right patient, right treatment.

Speaker: Doctor M. Bonaca (Aurora, US)

Thumbnail

Summary and Close - Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events.

Speaker: Professor D. Angiolillo (Jacksonville, US)

Thumbnail

Access the full session

Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)

Speakers: Professor S. James, Professor D. Angiolillo, Professor S. Nicholls, Doctor M. Bonaca, Professor S. James...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb